Multiple sclerosis and chronic autoimmune encephalomyelitis -: A comparative quantitative study of axonal injury in active, inactive, and remyelinated lesions

被引:729
作者
Kornek, B
Storch, MK
Weissert, R
Wallstroem, E
Stefferl, A
Olsson, T
Linington, C
Schmidbauer, M
Lassmann, H
机构
[1] Univ Vienna, Brain Res Inst, Div Neuroimmunol, A-1090 Vienna, Austria
[2] Karl Franzens Univ Graz, Dept Neurol, Graz, Austria
[3] Karolinska Hosp, Neuroimmunol Unit, Ctr Mol Med, S-10401 Stockholm, Sweden
[4] Max Planck Inst Neurobiol, Dept Neuroimmunol, Martinsried, Germany
[5] Lainz Hosp, Dept Neurol, Vienna, Austria
基金
奥地利科学基金会;
关键词
D O I
10.1016/S0002-9440(10)64537-3
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Recent magnetic resonance (MR) studies of multiple sclerosis lesions indicate that axonal injury is a major correlate of permanent clinical deficit. In the present study we systematically quantified acute axonal injury, defined by immunoreactivity for beta-amyloid-precursor-protein in dystrophic neurites, in the central nervous system of 22 multiple sclerosis patients and 18 rats with myelin-oligodendrocyte glycoprotein (MOG)-induced chronic autoimmune encephalomyelitis (EAE), The highest incidence of acute axonal injury was found during active demyelination, which was associated with axonal damage in periplaque and in the normal appearing white matter of actively demyelinating cases. In addition, low but significant axonal injury was also observed in attractive demyelinated plaques. In contrast, no significant axonal damage was found in remyelinated shadow plaques. The patterns of axonal pathology in chronic active EAE were qualitatively and quantitatively similar to those found in multiple sclerosis, Our studies confirm previous observations of axonal destruction in multiple sclerosis lesions during active demyelination, but also indicate that ongoing axonal damage in inactive lesions may significantly contribute to the clinical progression of the disease. The results further emphasize that MOG-induced EAE may serve as a suitable model for testing axon-protective therapies in inflammatory demyelinating conditions.
引用
收藏
页码:267 / 276
页数:10
相关论文
共 56 条
  • [1] Axonal damage revealed by accumulation of beta-APP in HIV-positive individuals without AIDS
    An, SF
    Giometto, B
    Groves, M
    Miller, RF
    Beckett, AAJ
    Gray, F
    Tavolato, B
    Scaravilli, F
    [J]. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 1997, 56 (11) : 1262 - 1268
  • [2] [Anonymous], 1970, Handbook of clinical neurology
  • [3] USE OF PROTON MAGNETIC-RESONANCE SPECTROSCOPY FOR MONITORING DISEASE PROGRESSION IN MULTIPLE-SCLEROSIS
    ARNOLD, DL
    RIESS, GT
    MATTHEWS, PM
    FRANCIS, GS
    COLLINS, DL
    WOLFSON, C
    ANTEL, JP
    [J]. ANNALS OF NEUROLOGY, 1994, 36 (01) : 76 - 82
  • [4] THE LONGSTANDING MS LESION - A QUANTITATIVE MRI AND ELECTRON-MICROSCOPIC STUDY
    BARNES, D
    MUNRO, PMG
    YOUL, BD
    PRINEAS, JW
    MCDONALD, WI
    [J]. BRAIN, 1991, 114 : 1271 - 1280
  • [5] Bielschowsky M, 1903, NEUROL CENTRALBLATT, V22, P770
  • [6] Bielschowsky m, 1904, NEUROL CENTRALBLATT, V16, P59
  • [7] BREITSCHOPF H, 1992, ACTA NEUROPATHOL, V84, P581
  • [8] MONOCYTE-MACROPHAGE DIFFERENTIATION IN EARLY MULTIPLE-SCLEROSIS LESIONS
    BRUCK, W
    PORADA, P
    POSER, S
    RIECKMANN, P
    HANEFELD, F
    KRETZSCHMAR, HA
    LASSMANN, H
    [J]. ANNALS OF NEUROLOGY, 1995, 38 (05) : 788 - 796
  • [9] OLIGODENDROCYTES IN THE EARLY COURSE OF MULTIPLE-SCLEROSIS
    BRUCK, W
    SCHMIED, M
    SUCHANEK, G
    BRUCK, Y
    BREITSCHOPF, H
    POSER, S
    PIDDLESDEN, S
    LASSMANN, H
    [J]. ANNALS OF NEUROLOGY, 1994, 35 (01) : 65 - 73
  • [10] Charcot JM, 1868, GAZ HOPITAUX, V41, P557